- CEO
- David Hong
- Full Time Employees
- 107
- Sector
- Consumer Defensive
- Industry
- Beverages - Non-Alcoholic
- Address
- 954 Lexington Avenue New York City NY United States of America 10021
- IPO Date
- Jan 16, 2013
- Business
- DND Technologies, Inc. DND Technologies, Inc. (DNDT) operates as a holding company focused on the production and distribution of specialty personal care and pharmaceutical products in the consumer staples sector. The company manufactures and sells various specialty balms along with pharmaceutical offerings under the Bioassaygen brand, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. It distributes these products through wholesale, retail, and internet channels, targeting consumer markets primarily in the United States, and operates subsidiaries such as THCA Beverage Company, Inc., which engages in the production, research, and development of infused beverage products. Founded in 1997 and headquartered at 954 Lexington Avenue, Suite 505, New York, New York, the company also pursues strategic investments and partnerships with next-generation startups to expand into new technology and market spaces, including research and development activities in business-to-business and business-to-consumer domains. Recent activities include late filings for the period ending March 31, 2024, reflecting ongoing operational reporting amid a focus on portfolio growth in personal care products and potential beverage innovations, with no major acquisitions or funding rounds announced in the past 1-2 years.